Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2010
Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phaseEdwin J Vazquez-Cintron, Ngozi R Monu, Alan B FreyPlos One|January 28, 2014
Atoxic derivative of botulinum neurotoxin A as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasmEdwin J Vazquez-Cintron, Maksim Vakulenko, Philip A Band, et al.Frontiers in Cellular Neuroscience|August 31, 2023
Neuromuscular recovery from botulism involves multiple forms of compensatory plasticityJames B Machamer, Edwin J Vazquez-Cintron, Mallory J Stenslik, et al.Plos One|May 9, 2012
Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cellsEdwin J Vazquez-Cintron, Ngozi R Monu, Jeremy C Burns, et al.Cephalalgia : an International Journal of Headache|May 13, 2022
Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headacheEdita Navratilova, Janice Oyarzo, Trent Anderson, et al.Molecular Medicine (Cambridge, Mass.)|June 6, 2022
Antidotal treatment of botulism in rats by continuous infusion with 3,4-diaminopyridineJames B Machamer, Edwin J Vazquez-Cintron, Sean W O'Brien, et al.Scientific Reports|February 22, 2017
Engineering Botulinum Neurotoxin C1 as a Molecular Vehicle for Intra-Neuronal Drug DeliveryEdwin J Vazquez-Cintron, Phillip H Beske, Luis Tenezaca, et al.Science Translational Medicine|January 7, 2021
Neuronal delivery of antibodies has therapeutic effects in animal models of botulismPatrick M McNutt, Edwin J Vazquez-Cintron, Luis Tenezaca, et al.Scientific Reports|June 15, 2022
Reengineering the specificity of the highly selective Clostridium botulinum protease via directed evolutionRebekah P Dyer, Hariny M Isoda, Gabriela S Salcedo, et al.Pageof 1